Histiocytic sarcoma in a 3-year-old male: A case report

Pediatrics

Volumn 116, Issue 2, 2005, Pages

  Buonocore, Samuel ^a   Valente, Alfredo L ^a   Nightingale, Daniel ^a   Bogart, Jeffrey ^a   Souid, Abdul Kader ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Histiocytes; Histiocytic sarcoma; Langerhans' cell histiocytosis; Sarcoma

Indexed keywords

6 MERPACTOPURINE; ANTINEOPLASTIC AGENT; CLADRIBINE; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; IDARUBICIN; METHOTREXATE; PREDNISONE; UNCLASSIFIED DRUG; VINBLASTINE;

ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DRUG TOLERANCE; HISTIOCYTOSIS X; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; SARCOMA; VERTEBRA BODY; LUMBAR VERTEBRA; LUNG TUMOR; PRESCHOOL CHILD; SPINAL CORD TUMOR; VERTEBRA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD, PRESCHOOL; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LUMBAR VERTEBRAE; LUNG NEOPLASMS; MALE; SARCOMA; SPINAL NEOPLASMS; THORACIC VERTEBRAE;

EID: 33644629196     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2005-0026     Document Type: Article

References (18)

1. Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002;41(1):1-29
2. Weiss LM, Grogan TM, Muller-Hermelink HK, et al. Histiocytic sarcoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. WHO Classification of Tumors: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. 2nd ed. Lyon, France: IARC Press; 2001:278-279
3. Copie-Bergman C, Wotherspoon AC, Norton AJ, Diss TC, Isaacson PG. True histiocytic lymphoma: a morphologic, immunohistochemical, and molecular genetic study of 13 cases. Am J Surg Pathol. 1998;22:1386-1392
4. Jaffe ES, Costa J, Fauci AS, Crossman J, Tsokos M. Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med. 1983;75:741-749
5. Pileri S, Falini B, Delsol G, et al. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1+ with a high content of reactive histiocytes). Histopathology. 1990;16:383-391
6. Lauritzen AF, Delsol G, Hansen NE, et al. Histiocytic sarcomas and monoblastic leukemias. A clinical, histologic, and immunophenotypical study. Am J Clin Pathol. 1994;102:45-54
7. Feldman AL, Minniti C, Santi M, Downing JR, Raffeld M, Jaffe ES. Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin. Lancet Oncol. 2004;5:248-250
8. van der Kwast TH, van Dongen JJ, Michiels JJ, Hooijkaas H, Kappers MC, Hagemeijer A. T-lymphoblastic lymphoma terminating as malignant histiocytosis with rearrangement of immunoglobulin heavy chain gene. Leukemia. 1991;5:78-82
9. Bouabdallah R, Abena P, Chetaille B, et al. True histiocytic lymphoma following B-acute lymphoblastic leukemia: case report with evidence for a common clonal origin in both neoplasms. Br J Haematol. 2001;113:1047-1050
10. Yu D, Allman D, Goldschmidt MH, Atchison ML, Monroe JG, Thomas-Tikhonenko A. Oscillation between B-lymphoid and myeloid lineages in Myc hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway. Blood. 2003;101:1950-1955
11. Ralfkiaer E, Delsol G, O'Connor NTJ, et al. Malignant lymphomas of true histiocytic origin. A clinical, histological, immunophenotypic and genotypic study. J Pathol. 1990;160:9-17
12. Sun W, Nordberg ML, Fowler R. Histiocytic sarcoma involving the central nervous system: clinical, immunohistochemical, and molecular genetic studies of a case with review of the literature. Am J Surg Pathol. 2003;27:258-265
13. Hornick JL, Jaffe ES, Fletcher C. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epitheliod malignancy. Am J Surg Pathol. 2004;28:1133-1144
14. Carrera CJ, Terai C, Lotz M, et al. Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy. J Clin Invest. 1990;86:1480-1488
15. Saven A, Foon KA, Piro LD. 2-Chlorodeoxyadenosine-induced complete remissions in Langerhans-cell histiocytosis. Ann Intern Med. 1994;121:430-432
16. Rodriguez-Galindo C, Kelly P, Jeng M, Presbury GG, Rieman M, Wang W. Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Am J Hematol. 2002;69:179-184
17. Garg S, Mehta S, Dormans JP. Langerhans cell histiocytosis of the spine in children. Long-term follow-up. J Bone Joint Surg Am. 2004;86-A:1740-1750
18. Egeler RM, Favara BE, Van Meurs M, Laman JD, Claassen E. Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood. 1999;94:4195-4201